Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AILERON THERAPEUTICS INC | 17,500 | reported | 23 Jul 2025 | tx 20+2,853,657−22,631,671 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Jul 2025 | GRANT_AWARD | AILERON THERAPEUTICS INC | 17,500 | 0.00 USD | deriv |
| 02 Dec 2024 | GRANT_AWARD | AILERON THERAPEUTICS INC | 35,000 | 0.00 USD | deriv |
| 20 Aug 2024 | GRANT_AWARD | AILERON THERAPEUTICS INC | 2,725 | 0.00 USD | deriv |
| 28 Feb 2024 | GRANT_AWARD | AILERON THERAPEUTICS INC | 2,725 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | AILERON THERAPEUTICS INC | 54,500 | 0.00 USD | deriv |
| 15 Jun 2021 | GRANT_AWARD | AILERON THERAPEUTICS INC | 96,000 | 0.00 USD | deriv |
| 17 Jun 2020 | GRANT_AWARD | AILERON THERAPEUTICS INC | 12,500 | 0.00 USD | deriv |
| 15 Jun 2020 | PURCHASE | AILERON THERAPEUTICS INC | 5,800 | 1.22 USD | first after silence |
| 19 Jun 2019 | GRANT_AWARD | AILERON THERAPEUTICS INC | 50,000 | 0.00 USD | deriv |
| 21 Jun 2018 | GRANT_AWARD | AILERON THERAPEUTICS INC | 10,000 | 0.00 USD | deriv |
| 26 Sept 2017 | GRANT_AWARD | AILERON THERAPEUTICS INC | 20,000 | 0.00 USD | deriv |
| 05 Jul 2017 | CONVERSION | AILERON THERAPEUTICS INC | 2,277,515 | — | |
| 05 Jul 2017 | PURCHASE | AILERON THERAPEUTICS INC | 266,667 | 15.00 USD | |
| 05 Jul 2017 | CONVERSION | AILERON THERAPEUTICS INC | 3,705,882 | 0.00 USD | deriv |
| 05 Jul 2017 | CONVERSION | AILERON THERAPEUTICS INC | 2,293,829 | 0.00 USD | deriv |
| 05 Jul 2017 | CONVERSION | AILERON THERAPEUTICS INC | 2,644,558 | 0.00 USD | deriv |
| 05 Jul 2017 | CONVERSION | AILERON THERAPEUTICS INC | 6,781,770 | 0.00 USD | deriv |
| 05 Jul 2017 | CONVERSION | AILERON THERAPEUTICS INC | 2,967,025 | 0.00 USD | deriv |
| 05 Jul 2017 | CONVERSION | AILERON THERAPEUTICS INC | 4,238,607 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 15 Jun 2020.